Michael Lopez

Assistant Professor

The University of Alabama

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Michael Lopez is an Assistant Professor at the University of Alabama at Birmingham, USA. His research focuses on neuromuscular diseases, particularly muscular dystrophies and myopathies, as evidenced by his recent publications on therapeutic approaches and molecular signatures in muscle conditions. He employs innovative models and methodologies to explore the underlying mechanisms and potential treatments for these disorders.

Articles (12)

Year:

2025

Year:

2025

Year:

2025

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (5)

Vandana Gupta

Assistant Professor

Brigham and Women's Hospital

UNITED STATES

View details

Peter King

The University of Alabama

UNITED STATES

View details

Matthew Alexander

Associate Professor

UNITED STATES

View details

Merry-Lynn McDonald

The University of Alabama

UNITED STATES

View details

David A. Schneider

The University of Alabama

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Michael Lopez

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Late‐Stage Skeletal Muscle Transcriptome in Duchenne Muscular Dystrophy Shows a BMP4‐Induced Molecular Signature

miR-33 inhibition as a novel therapeutic approach for treating muscular dystrophy

X-linked myopathy with excessive autophagy: characterization and therapy testing in a zebrafish model

DOCKopathies: A systematic review of the clinical pathologies associated with human DOCK pathogenic variants

Smad8 Is Increased in Duchenne Muscular Dystrophy and Suppresses miR-1, miR-133a, and miR-133b

Pediatric Nemaline Myopathy: A Systematic Review Using Individual Patient Data.

miR-486 is essential for muscle function and suppresses a dystrophic transcriptome

Clinical exome sequencing in the diagnosis of pediatric neuromuscular disease

Mechanics of dystrophin deficient skeletal muscles in very young mice and effects of age

DOCK3 is a dosage-sensitive regulator of skeletal muscle and Duchenne muscular dystrophy-associated pathologies.

DOCK3 is a dosage-sensitive regulator of skeletal muscle and Duchenne muscular dystrophy-associated pathologies

Fibulin-5 mutation featuring Charcot-Marie-Tooth disease, joint hyperlaxity, and scoliosis

Collaborators (5)

Vandana Gupta

Peter King

Matthew Alexander

Merry-Lynn McDonald

David A. Schneider

Make your next move.